We are thrilled to announce that the patent for our ground-breaking S4 Pro servo proportional valve has been granted in China. Bolstering our existing patents around the world, this marks a significant milestone in strengthening our position as innovators within hydraulics in the Asia-Pacific region .
The newly granted patent for our direct drive valve technology highlights our unwavering dedication to innovation and technological progress in hydraulic systems.
Revolutionising Industries
“Since we secured patents for this technology in the UK and USA, in 2023 our S4 Pro has been transforming our customers’ operations worldwide” says Simon Jones, CTO at Domin.
“Extending this patent to China and continuing to strengthen our position as industry leaders is incredible. We are committed to leading the charge on bringing the fluid power industry into a modern, electrified, sustainable world.”
The S4 Pro is a high-performance servo proportional valve featuring a direct drive design that delivers unmatched accuracy and responsiveness in motion control applications. The patent encompasses the distinctive and innovative aspects of the S4 Pro, particularly its rotary valve architecture.
As the smallest direct drive valve in the world, the S4 Pro is a game-changer in its applications across cutting edge robotics, motorsport, simulation, and anywhere that space is limited but performance is critical.
https://vimeo.com/985551837?share=copy
The World’s Smallest Direct Drive Valve
“We are excited to continue delivering this cutting-edge technology to our customers, enabling them to achieve outstanding performance in their critical applications” Simon continues.
“The extension of this patent to China really does reflect the expertise and dedication of the team here at Domin. This innovative technology is transforming the high-performance servo valve market.”
The new patent provides us with the legal framework to prevent any unauthorised manufacturing or sale of products that infringe upon this innovative technology within China. This expanded protection complements our existing coverage in the UK and the United States.
